scholarly article | Q13442814 |
P819 | ADS bibcode | 1992PNAS...8910772S |
P356 | DOI | 10.1073/PNAS.89.22.10772 |
P953 | full work available at URL | https://europepmc.org/articles/PMC50424 |
https://europepmc.org/articles/PMC50424?pdf=render | ||
P932 | PMC publication ID | 50424 |
P698 | PubMed publication ID | 1438274 |
P5875 | ResearchGate publication ID | 21717992 |
P50 | author | David E. Szymkowski | Q37838817 |
P2093 | author name string | R. D. Wood | |
J. M. Essigmann | |||
S. J. Lippard | |||
K. Yarema | |||
P2860 | cites work | Enhanced host cell reactivation of damaged plasmid DNA in HeLa cells resistant to cis-diamminedichloroplatinum(II) | Q67982271 |
Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II) | Q68183300 | ||
Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines | Q68343885 | ||
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA | Q69586643 | ||
In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication | Q70126283 | ||
Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines | Q70404759 | ||
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation | Q93607580 | ||
Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin | Q24562722 | ||
Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II) | Q24604428 | ||
Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA | Q28292106 | ||
Drugs five years later. Cisplatin | Q34257493 | ||
Complementation of DNA repair in xeroderma pigmentosum group A cell extracts by a protein with affinity for damaged DNA. | Q35935973 | ||
Sites of termination of in vitro DNA synthesis on cis-diamminedichloroplatinum(II) treated single-stranded DNA: a comparison between E. coli DNA polymerase I and eucaryotic DNA polymerases alpha | Q36005271 | ||
Human nucleotide excision nuclease removes thymine dimers from DNA by incising the 22nd phosphodiester bond 5' and the 6th phosphodiester bond 3' to the photodimer | Q36968114 | ||
Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II). | Q37523234 | ||
Replication inhibition and translesion synthesis on templates containing site- specifically placed cis-diamminedichloroplatinum(II) DNA adducts | Q38329239 | ||
Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin | Q38329454 | ||
DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II). | Q38333904 | ||
Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin | Q38340395 | ||
Substrate overlap and functional competition between human nucleotide excision repair and Escherichia coli photolyase and (a)BC excision nuclease | Q38340400 | ||
Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis-[Pt(NH3)2(N3-cytosine)Cl]+. | Q38341322 | ||
Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2(d(GpG]], built into a specific site in a viral genome | Q38347089 | ||
Human nucleotide excision repair in vitro: repair of pyrimidine dimers, psoralen and cisplatin adducts by HeLa cell-free extract. | Q40450557 | ||
Reactions of the UVRABC excision nuclease with DNA damaged by diamminedichloroplatinum(II). | Q40472204 | ||
Complementation of the xeroderma pigmentosum DNA repair synthesis defect with Escherichia coli UvrABC proteins in a cell-free system | Q40513521 | ||
Repair synthesis by human cell extracts in DNA damaged by cis- and trans-diamminedichloroplatinum(II). | Q40538207 | ||
Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication | Q41202176 | ||
Excision repair of cis-diamminedichloroplatinum(II)-induced damage to DNA of Chinese hamster cells | Q41487235 | ||
Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells | Q41687395 | ||
Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation. | Q41728494 | ||
Localization of DNA repair synthesis by human cell extracts to a short region at the site of a lesion. | Q41757759 | ||
Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cis-diamminedichloroplatinum (II). | Q41881603 | ||
Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts. | Q43484172 | ||
DNA excision repair in cell extracts from human cell lines exhibiting hypersensitivity to DNA-damaging agents | Q44551787 | ||
Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). | Q52832659 | ||
Efficient synthesis of a supercoiled M13 DNA molecule containing a site specifically placed psoralen adduct and its use as a substrate for DNA replication. | Q54235179 | ||
Role of carrier ligand in platinum resistance in L1210 cells. | Q54313675 | ||
Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality. | Q54332081 | ||
Specific strand loss in N-2-acetylaminofluorene-modified DNA. | Q54767243 | ||
Complementation of the xeroderma pigmentosum DNA repair defect in cell-free extracts. | Q55060652 | ||
Effect of exogenous DNA fragments on human cell extract-mediated DNA repair synthesis | Q60311339 | ||
Requirement for the replication protein SSB in human DMA excision repair | Q60311342 | ||
P433 | issue | 22 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | platinum | Q880 |
DNA repair | Q210538 | ||
P304 | page(s) | 10772-10776 | |
P577 | publication date | 1992-11-01 | |
1992-11-15 | |||
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts | |
P478 | volume | 89 |
Q36785185 | A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells |
Q33893171 | A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cells |
Q39715713 | A repair competition assay to assess recognition by human nucleotide excision repair |
Q72422002 | Accumulation of platinum in the intervertebral discs and vertebrae of ovarian tumor-bearing patients treated with cisplatin |
Q36566743 | An XPG DNA repair defect causing mutagen hypersensitivity in mouse leukemia L1210 cells |
Q28829273 | An in vitro method for detecting genetic toxicity based on inhibition of RNA synthesis by DNA lesions |
Q36799639 | Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d(GpTpG)-cisplatin adduct |
Q33649960 | Biological properties of single chemical-DNA adducts: a twenty year perspective |
Q84593041 | Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT116 |
Q44281098 | Changes in endogenous tissue glutathione level in relation to murine ascites tumor growth and the anticancer activity of cisplatin |
Q41166774 | Chromatin assembly coupled to DNA repair: a new role for chromatin assembly factor I. |
Q41423739 | Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair |
Q36149816 | Cisplatin damage: are DNA repair proteins saviors or traitors to the cell? |
Q35518363 | Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor). |
Q33635353 | Current gene expression studies in esophageal carcinoma |
Q33601030 | DNA damage excision repair in microplate wells with chemiluminescence detection: development and perspectives. |
Q37358566 | DNA damage tolerance and a web of connections with DNA repair at Yale |
Q34625375 | Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts |
Q54649579 | Effects of a single intrastrand d(GpG) platinum adduct on the strand separating activity of the Escherichia coli proteins RecB and RecA. |
Q28296085 | Formation and repair of interstrand cross-links in DNA |
Q35852579 | HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease |
Q24561381 | High-efficiency bypass of DNA damage by human DNA polymerase Q |
Q38340847 | High-mobility group 1 protein inhibits helicase catalyzed displacement of cisplatin-damaged DNA. |
Q54462984 | Human DNA polymerase N (POLN) is a low fidelity enzyme capable of error-free bypass of 5S-thymine glycol. |
Q45770163 | In vitro bypass replication of the cisplatin-d(GpG) lesion by calf thymus DNA polymerase beta and human immunodeficiency virus type I reverse transcriptase is highly mutagenic |
Q53712743 | In vitro enhancement of antitumor activity of a water-soluble duocarmycin derivative, KW-2189, by caffeine-mediated DNA-repair inhibition in human lung cancer cells. |
Q40997032 | Lack of correlation between repair of DNA interstrand cross-links and hypersensitivity of hamster cells towards mitomycin C and cisplatin |
Q34282241 | Mechanisms of resistance to cisplatin |
Q34866688 | Molecular aspects of resistance to antitumor platinum drugs. |
Q40400417 | Mutagenesis in monkey cells of a vector containing a single d(GPG) cis-diamminedichloroplatinum(II) adduct placed on codon 13 of the human H-ras proto-oncogene |
Q36591929 | Overexpression of cyclin B1 antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt pathway in human esophageal squamous cell carcinoma cells |
Q34671647 | Particular aspects of platinum compounds used at present in cancer treatment |
Q30755683 | Photocrosslinking locates a binding site for the large subunit of human replication protein A to the damaged strand of cisplatin-modified DNA |
Q33180580 | Preclinical perspectives on platinum resistance |
Q73502663 | Preferential formation and decreased removal of cisplatin–DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA |
Q35888670 | Rapid gene-specific repair of cisplatin lesions at the human DUG/DHFR locus comprising the divergent upstream gene and dihydrofolate reductase gene during early G1 phase of the cell cycle assayed by using the exonucleolytic activity of T4 DNA polyme |
Q41886077 | Recognition of DNA alterations by the mismatch repair system |
Q36615580 | Repair by human cell extracts of single (6-4) and cyclobutane thymine-thymine photoproducts in DNA |
Q43875766 | Repair of damaged DNA by Arabidopsis cell extract |
Q44242635 | Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibodies Perspective |
Q28082382 | Review of Cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments |
Q35009287 | Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage |
Q34625095 | Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins. |
Q40707413 | Studying nucleotide excision repair of mammalian DNA in a cell-free system |
Q54266410 | Synthesis, Characterization, and Repair of a Flexible O(6) -2'-Deoxyguanosine-alkylene-O(6) -2'-deoxyguanosine Intrastrand Cross-Link. |
Q58318854 | Transcription factor b (TFIIH) is required during nucleotide-excision repair in yeast |
Q33878705 | Up-regulation of Fas reverses cisplatin resistance of human small cell lung cancer cells |
Q39936122 | Vanillins--a novel family of DNA-PK inhibitors |
Q24320768 | XPG endonuclease makes the 3' incision in human DNA nucleotide excision repair |
Search more.